Insider Shareholders with Direct Ownership of Clarus Therapeutics Holdings, Inc. (CRXT)
This section provides a comprehensive overview of the insiders with direct ownership of Clarus Therapeutics Holdings, Inc. (CRXT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Clarus Therapeutics Holdings, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Joseph Hernandez
Director |
1,243,266 | 0 | 1,243,266 $37,297 | 3 |
Jun 07, 2022
Added 0.15%
|
|
Robert E. Dudley
Chief Executive Officer |
139,566 | 0 | 139,566 $4,186 | 2 |
Dec 12, 2021
Added 49.17%
|
|
Richard D Peterson
Chief Financial Officer |
55,800 | 0 | 55,800 $1,674 | 1 |
Dec 11, 2021
Added 50.0%
|
|
Steven A. Bourne
Chief Administrative Officer |
30,305 | 0 | 30,305 $909 | 2 |
Dec 11, 2021
Added 48.9%
|
|
Frank Jaeger
Chief Commercial Officer |
29,000 | 0 | 29,000 $870 | 1 |
Dec 11, 2021
Added 50.0%
|
|
Elizabeth Cermak
Director |
5,766 | 0 | 5,766 $172 | 2 |
Jun 07, 2022
Added 25.0%
|
|
Kimberly M Murphy
Director |
5,766 | 0 | 5,766 $172 | 2 |
Jun 07, 2022
Added 25.0%
|
|
Mark A Sr Prygocki
Director |
5,766 | 0 | 5,766 $172 | 2 |
Jun 07, 2022
Added 25.0%
|
|
John Kenneth Amory
Director |
5,766 | 0 | 5,766 $172 | 2 |
Jun 07, 2022
Added 25.0%
|